Eton Pharmaceuticals Inc Stock Ownership - Who owns Eton Pharmaceuticals?

Insider buying vs selling

Have Eton Pharmaceuticals Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when ETON insiders and whales buy or sell their stock.

ETON Shareholders

What type of owners hold Eton Pharmaceuticals Inc stock?
Opaleye Management Inc9.58%2,460,000$8.24MInsider
Opaleye Management Inc9.52%2,445,781$8.19MInstitution
Harrow Health Inc7.71%1,982,000$6.64MInsider
Sean Brynjelsen4.15%1,064,940$3.57MInsider
Vanguard Group Inc4.00%1,027,688$3.44MInstitution
Acuitas Investments LLC2.26%579,960$1.94MInstitution
Westside Investment Management Inc2.23%573,960$1.92MInstitution
Paradigm Capital Management Inc1.17%300,000$1.01MInstitution
Blackrock Inc1.10%282,952$947.89kInstitution
Bridgeway Capital Management LLC0.99%253,362$848.76kInstitution

1 of 3

ETON vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SCYX39.19%22.05%Net Selling
EGRX23.95%76.05%Net Selling
RMTI14.60%85.40%Net Selling

Eton Pharmaceuticals Stock Ownership FAQ

Who owns Eton Pharmaceuticals?

Eton Pharmaceuticals (NASDAQ: ETON) is owned by 27.96% institutional shareholders, 21.84% Eton Pharmaceuticals insiders, and 50.20% retail investors. Opaleye Management Inc is the largest individual Eton Pharmaceuticals shareholder, owning 2.46M shares representing 9.58% of the company. Opaleye Management Inc's Eton Pharmaceuticals shares are currently valued at $8.44M.

If you're new to stock investing, here's how to buy Eton Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.